Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
Document › Details

Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris.

Region Region Paris
  Country France
Organisations Organisation Lysogene S.A. (Euronext Paris: LYS)
  Organisation 2 Euronext Paris S.A.
  Group Euronext (Group)
Products Product gene therapy
  Product 2 financial services
Index term Index term Lysogene–SEVERAL: investment, 201701–201702 IPO €22.6m w 3.32m new shares at €6.8/share at Euronext Paris
Person Person Aiach, Karen (Lysogene 201206 CEO + Founder)

Record changed: 2023-06-05


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for Lysogene S.A. (Euronext Paris: LYS)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top